Literature DB >> 16439123

Kinesin spindle protein (KSP) inhibitors. Part 2: the design, synthesis, and characterization of 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP.

Mark E Fraley1, Robert M Garbaccio, Kenneth L Arrington, William F Hoffman, Edward S Tasber, Paul J Coleman, Carolyn A Buser, Eileen S Walsh, Kelly Hamilton, Christine Fernandes, Michael D Schaber, Robert B Lobell, Weikang Tao, Victoria J South, Youwei Yan, Lawrence C Kuo, Thomayant Prueksaritanont, Cathy Shu, Maricel Torrent, David C Heimbrook, Nancy E Kohl, Hans E Huber, George D Hartman.   

Abstract

The evolution of 2,4-diaryl-2,5-dihydropyrroles as inhibitors of KSP is described. Introduction of basic amide and urea moieties to the dihydropyrrole nucleus enhanced potency and aqueous solubility, simultaneously, and provided compounds that caused mitotic arrest of A2780 human ovarian carcinoma cells with EC(50)s<10nM. Ancillary hERG activity was evaluated for this series of inhibitors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16439123     DOI: 10.1016/j.bmcl.2006.01.030

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  11 in total

1.  Allosteric drug discrimination is coupled to mechanochemical changes in the kinesin-5 motor core.

Authors:  Elizabeth D Kim; Rebecca Buckley; Sarah Learman; Jessica Richard; Courtney Parke; David K Worthylake; Edward J Wojcik; Richard A Walker; Sunyoung Kim
Journal:  J Biol Chem       Date:  2010-03-18       Impact factor: 5.157

2.  Docking studies on kinesin spindle protein inhibitors: an important cooperative 'minor binding pocket' which increases the binding affinity significantly.

Authors:  Cheng Jiang; Yadong Chen; Xiaojian Wang; Qidong You
Journal:  J Mol Model       Date:  2007-06-23       Impact factor: 1.810

3.  ADMET evaluation in drug discovery. 12. Development of binary classification models for prediction of hERG potassium channel blockage.

Authors:  Sichao Wang; Youyong Li; Junmei Wang; Lei Chen; Liling Zhang; Huidong Yu; Tingjun Hou
Journal:  Mol Pharm       Date:  2012-03-16       Impact factor: 4.939

4.  Pathway of ATP hydrolysis by monomeric kinesin Eg5.

Authors:  Jared C Cochran; Troy C Krzysiak; Susan P Gilbert
Journal:  Biochemistry       Date:  2006-10-10       Impact factor: 3.162

5.  3D-QSAR studies of dihydropyrazole and dihydropyrrole derivatives as inhibitors of human mitotic kinesin Eg5 based on molecular docking.

Authors:  Xingyan Luo; Mao Shu; Yuanqiang Wang; Jin Liu; Wenjuan Yang; Zhihua Lin
Journal:  Molecules       Date:  2012-02-17       Impact factor: 4.411

Review 6.  Kinesin-5: cross-bridging mechanism to targeted clinical therapy.

Authors:  Edward J Wojcik; Rebecca S Buckley; Jessica Richard; Liqiong Liu; Thomas M Huckaba; Sunyoung Kim
Journal:  Gene       Date:  2013-08-14       Impact factor: 3.688

7.  Chemical and structural studies provide a mechanistic basis for recognition of the MYC G-quadruplex.

Authors:  David R Calabrese; Xiang Chen; Elena C Leon; Snehal M Gaikwad; Zaw Phyo; William M Hewitt; Stephanie Alden; Thomas A Hilimire; Fahu He; Aleksandra M Michalowski; John K Simmons; Lindsey B Saunders; Shuling Zhang; Daniel Connors; Kylie J Walters; Beverly A Mock; John S Schneekloth
Journal:  Nat Commun       Date:  2018-10-12       Impact factor: 14.919

8.  hERG1 is involved in the pathophysiological process and inhibited by berberine in SKOV3 cells.

Authors:  Duo Zhi; Kun Zhou; Dahai Yu; Xiaofan Fan; Juan Zhang; Xiang Li; Mei Dong
Journal:  Oncol Lett       Date:  2019-04-17       Impact factor: 2.967

9.  KIF11 inhibition for glioblastoma treatment: reason to hope or a struggle with the brain?

Authors:  Silvia Valensin; Chiara Ghiron; Claudia Lamanna; Andreas Kremer; Marco Rossi; Pietro Ferruzzi; Marco Nievo; Annette Bakker
Journal:  BMC Cancer       Date:  2009-06-22       Impact factor: 4.430

10.  Chromosome 20q amplification regulates in vitro response to Kinesin-5 inhibitor.

Authors:  Aimee L Jackson; Mao Mao; Sumire Kobayashi; Teresa Ward; Matthew Biery; Hongyue Dai; Steven R Bartz; Peter S Linsley
Journal:  Cancer Inform       Date:  2008-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.